| Spirig HealthCare AG - FemiRing, Vaginalring |
| 66569 | | 01 | | FemiRing | | Vaginalring | | G02BB01 | | Vaginalring mit Gestagenen und Estrogenen | | 25.04.2018 | | |
|
| Composition |
| etonogestrelum 8.25 mg, ethinylestradiolum 2.6 mg, polyurethanum, ethyleni et vinylis acetatis polymerisatum, pro praeparatione. |
| Packungsbestandteile |
| Anneau vaginal | | | | | | Principe actif | Concentr. |
|---|
| Ethinyl Estradiol | 2.6 mg | | Etonogestrel | 8.25 mg |
| | | | Agents auxilliaires |
|---|
| Ethyleni | | Polyurethanum | | Vinylis Acetatis Polymerisatum |
|
|
|
